Evanthia Roussos Torres, MD, PhD
|
| Title(s) | Assistant Professor of Medicine and Cancer Biology |
|---|
| School | Keck School of Medicine of Usc |
|---|
| Address | NOR 6412 NTT
Health Sciences Campus
Los Angeles CA 90089
|
|---|
ORCID
.gif) | 0000-0002-0740-5102  |
|---|
| vCard | Download vCard |
|---|
|
|
| Title(s) | Program Leader for Tumor Immunology and Microenvironment (TIME) Program |
|---|
|
|---|
|
Overview
Dr. Roussos Torres received a BS in Microbiology, Immunology and Molecular Genetics and a BA in World Arts and Cultures with a concentration in Dance from the University of California at Los Angeles (UCLA). She then went on to receive her combined MD/PhD from the Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. She then completed her internal medicine residency at the Hospital of the University of Pennsylvania and her hematology/ oncology fellowship training at the University of Pennsylvania and Johns Hopkins University. Dr. Roussos Torres graduated from fellowship and began her faculty career as an Assistant Professor at Johns Hopkins University and is now an Assistant Professor at the University of Southern California where she leads her own lab and works collaboratively with other physicians and physician scientists to continue her work in immune-oncology with a specific interest in breast cancer and the tumor immune suppressive microenvironment.
Dr. Roussos Torres is very passionate about her research as well as her care of patients with cancer and training of the fellows to become compassionate and knowledgeable physicians. She is driven to make memorable contributions to the field of cancer research given her personal experience advocating for her mother who died from metastatic breast cancer in 2016. Dr. Roussos Torres felt passionate about having an impact on the field of breast cancer prior to her mother’s diagnosis but learning about the devastation of metastatic disease as the family member of a patient provided a different perspective and drive for novel treatment options.
Dr. Roussos Torres loves her work but also prioritizes her family life; her husband Dr. Stephen Torres is an orthopedic surgeon, specializing in sports medicine and together they have three sons, Owen, James and Luke who fill their life with joy and make every day a wonder! The Torres family also has a Chesapeake Bay retriever, Emma who greatly contributes to her active lifestyle! Dr. Roussos Torres enjoys traveling, eating out at new restaurants and road biking! Dr. Roussos Torres grew up in Santa Monica and is so happy to work close to where she grew up to raise her family near her siblings, their families, and her father who still resides here.
Laboratory website: https://sites.usc.edu/roussostorreslab/
Publications library: https://www-ncbi-nlm-nihgov.libproxy2.usc.edu/myncbi/1pwdQqmmnMeUHt/bibliography/public/
Featured Content
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer. Cancer Res. 2026 Aug 11.
Gonzalez E, Kreger J, Liu Y, Wu X, Barbetta A, Baugh AG, Al-Zubeidy B, Jang JK, Shin SM, Zhang Z, Poissonnier A, Jacobo M, Stearns V, Connolly RM, Ho WJ, Emamaullee J, MacLean AL, Roussos Torres ET. PMID: 42578817; PMCID: PMC13592381.
View in:
PubMed Mentions:
-
Inference of marker genes of subtle cell state changes via iLR: iterative logistic regression. Bioinformatics. 2026 02 03; 42(2).
Liu Y, Baugh AG, Roussos Torres ET, MacLean AL. PMID: 41627891; PMCID: PMC12925251.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
-
High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 09; 45(9):e70255.
Ennin E, Mallepally N, Ali M, Shojaie L, Dewberry S, Trieu M, Torres ETR, Zhou K, Kahn J, Dodge JL, Dara L. PMID: 40778804; PMCID: PMC12345591.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancer. Oncogene. 2025 Aug; 44(30):2565-2573.
Jayachandran P, Elliott A, Soni S, Battaglin F, Mittal P, Algaze S, Lo JH, Yang Y, Ashouri K, Roussos Torres ET, Zhang W, Millstein J, Zhang L, Yu J, Lenz HJ. PMID: 40615690; PMCID: PMC12277178.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimals
-
Association of Androgen Receptor Expression With Tumor Immune Landscape and Treatment Outcomes of Patients With Breast Cancer. JCO Precis Oncol. 2025 Apr; 9:e2400459.
Jayachandran P, Deshmukh SK, Wu S, Ribeiro JR, Kang I, Xiu J, Farrell A, Battaglin F, Spicer DV, Soni S, Zhang W, Ashouri K, Millstein J, Ma CX, Graff SL, Radovich M, Sledge GW, Lenz HJ, Roussos Torres ET. PMID: 40294352.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Modeling the dynamics of EMT reveals genes associated with pan-cancer intermediate states and plasticity. NPJ Syst Biol Appl. 2025 Apr 10; 11(1):31.
McDermott M, Mehta R, Roussos Torres ET, MacLean AL. PMID: 40210876; PMCID: PMC11986130.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Integrated workflow for analysis of immune enriched spatial proteomic data with IMmuneCite. Sci Rep. 2025 Mar 19; 15(1):9394.
Barbetta A, Bangerth S, Lee JTC, Rocque B, Roussos Torres ET, Kohli R, Akbari O, Emamaullee J. PMID: 40102469; PMCID: PMC11920390.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansAnimals
-
Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer Mortality. Cancer Res. 2024 12 02; 84(23):3924-3935.
Falcone M, Salhia B, Hughes Halbert C, Roussos Torres ET, Stewart D, Stern MC, Lerman C. PMID: 39356624; PMCID: PMC11611670.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Hypoxic Memory Mediates Prolonged Tumor-Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression. Cancer Res. 2024 10 01; 84(19):3141-3157.
Iriondo O, Mecenas D, Li Y, Chin CR, Thomas A, Moriarty A, Marker R, Wang YJ, Hendrick H, Amzaleg Y, Ortiz V, MacKay M, Dickerson A, Lee G, Harotoonian S, Benayoun BA, Smith A, Mason CE, Roussos Torres ET, Klotz R, Yu M. PMID: 38990731; PMCID: PMC11444891.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansAnimalsCells
-
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3728-3736.
Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277671; PMCID: PMC12044543.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansCTClinical Trials
-
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747.
Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. PMID: 39277672; PMCID: PMC12089997.
View in:
PubMed Mentions:
20 Fields:
Translation:
HumansCTClinical Trials
-
Digital droplet PCR analysis of organoids generated from mouse mammary tumors demonstrates proof-of-concept capture of tumor heterogeneity. Front Cell Dev Biol. 2024; 12:1358583.
Lake KE, Colonnetta MM, Smith CA, Saunders K, Martinez-Algarin K, Mohta S, Pena J, McArthur HL, Reddy SM, Roussos Torres ET, Chen EH, Chan IS. PMID: 38827528; PMCID: PMC11140600.
View in:
PubMed Mentions:
2
-
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer. Clin Exp Metastasis. 2024 10; 41(5):733-746.
Baugh AG, Gonzalez E, Narumi VH, Kreger J, Liu Y, Rafie C, Castanon S, Jang J, Kagohara LT, Anastasiadou DP, Leatherman J, Armstrong T, Chan I, Karagiannis GS, Jaffee EM, MacLean A, Roussos Torres ET. PMID: 38717519; PMCID: PMC11499368.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansAnimalsCells
-
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer. Breast Cancer Res Treat. 2024 Jul; 206(2):245-259.
Hsu R, Al-Zubeidy B, Flores D, Nazarian A, Baugh A, Gonzalez E, Castanon S, Xiu J, Kang I, Spicer D, Lenz HJ, Dara L, Ademuyiwa FO, Korn WM, Irshad S, Chan IS, Roussos Torres ET. PMID: 38643348; PMCID: PMC11182800.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansCells
-
A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response. Cell Rep Med. 2024 May 21; 5(5):101511.
Xu L, Saunders K, Huang SP, Knutsdottir H, Martinez-Algarin K, Terrazas I, Chen K, McArthur HM, Maués J, Hodgdon C, Reddy SM, Roussos Torres ET, Xu L, Chan IS. PMID: 38614094; PMCID: PMC11148512.
View in:
PubMed Mentions:
50 Fields:
Translation:
HumansCells
-
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nat Cancer. 2024 Jun; 5(6):866-879.
Roussos Torres ET, Ho WJ, Danilova L, Tandurella JA, Leatherman J, Rafie C, Wang C, Brufsky A, LoRusso P, Chung V, Yuan Y, Downs M, O'Connor A, Shin SM, Hernandez A, Engle EL, Piekarz R, Streicher H, Talebi Z, Rudek MA, Zhu Q, Anders RA, Cimino-Mathews A, Fertig EJ, Jaffee EM, Stearns V, Connolly RM. PMID: 38355777; PMCID: PMC11552660.
View in:
PubMed Mentions:
25 Fields:
Translation:
HumansCTClinical Trials
-
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value. J Immunother Cancer. 2024 01 11; 12(1).
Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, Wang J, Ou FS, Innocenti F, Mumenthaler SM, Jayachandran P, Kawanishi N, Lenz A, Soni S, Algaze S, Zhang W, Khoukaz T, Roussos Torres E, Seeber A, Abraham JP, Lou E, Philip PA, Weinberg BA, Shields AF, Goldberg RM, Marshall JL, Venook AP, Korn WM, Lenz HJ. PMID: 38212126; PMCID: PMC10806545.
View in:
PubMed Mentions:
8 Fields:
Translation:
Humans
-
Evaluating the impact of age on immune checkpoint therapy biomarkers. Cell Rep. 2021 08 24; 36(8):109599.
Erbe R, Wang Z, Wu S, Xiu J, Zaidi N, La J, Tuck D, Fillmore N, Giraldo NA, Topper M, Baylin S, Lippman M, Isaacs C, Basho R, Serebriiskii I, Lenz HJ, Astsaturov I, Marshall J, Taverna J, Lee J, Jaffee EM, Roussos Torres ET, Weeraratna A, Easwaran H, Fertig EJ. PMID: 34433020; PMCID: PMC8757482.
View in:
PubMed Mentions:
34 Fields:
Translation:
Humans
-
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844). Clin Cancer Res. 2021 11 01; 27(21):5828-5837.
Roussos Torres ET, Rafie C, Wang C, Lim D, Brufsky A, LoRusso P, Eder JP, Chung V, Downs M, Geare M, Piekarz R, Streicher H, Anforth L, Rudek MA, Zhu Q, Besharati S, Cimino-Mathews A, Anders RA, Stearns V, Jaffee EM, Connolly RM. PMID: 34135021; PMCID: PMC8563383.
View in:
PubMed Mentions:
26 Fields:
Translation:
Humans
-
Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor Response. Front Mol Biosci. 2021; 8:674558.
Goode EF, Roussos Torres ET, Irshad S. PMID: 34141724; PMCID: PMC8205515.
View in:
PubMed Mentions:
17
-
Clocking cancer: the circadian clock as a target in cancer therapy. Oncogene. 2021 May; 40(18):3187-3200.
Battaglin F, Chan P, Pan Y, Soni S, Qu M, Spiller ER, Castanon S, Roussos Torres ET, Mumenthaler SM, Kay SA, Lenz HJ. PMID: 33846572; PMCID: PMC8549632.
View in:
PubMed Mentions:
54 Fields:
Translation:
HumansAnimals
-
Phenotypic shifts of tumor associated macrophages and STAT3 mediated suppression of myeloid derived suppressor cells drive sensitization of HER2+ tumor immunity. bioRxiv. 2021.
Sidiropoulos DN, Rafie C, Christmas BJ, Davis-Marcisak EF, Sharma G, Bigelow E, Gupta A, Yegnasubramanian S, Stearns V, Connolly RM, Gaykalova DA, Kagohara LT, Jaffee EM, Fertig EJ, Roussos Torres ET. View Publication.
-
Adopting an alternative structure for clinical trials in immunotherapy. Expert Rev Anticancer Ther. 2021 04; 21(4):373-375.
Roussos Torres ET, Epstein AL. PMID: 33435760.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO Oncol Pract. 2020 Oct; 16(10):665-674.
Sheng JY, Santa-Maria CA, Mangini N, Norman H, Couzi R, Nunes R, Wilkinson M, Visvanathan K, Connolly RM, Roussos Torres ET, Fetting JH, Armstrong DK, Tao JJ, Jacobs L, Wright JL, Thorner ED, Hodgdon C, Horn S, Wolff AC, Stearns V, Smith KL. PMID: 32603252; PMCID: PMC7564133.
View in:
PubMed Mentions:
35 Fields:
Translation:
HumansCellsPHPublic Health
-
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide. Oncoimmunology. 2020 05 14; 9(1):1760685.
Mirando AC, Patil A, Rafie CI, Christmas BJ, Pandey NB, Stearns V, Jaffee EM, Roussos Torres ET, Popel AS. PMID: 32923118; PMCID: PMC7458646.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimals
-
Best Foot Forward: Neoadjuvant Systemic Therapy as Standard of Care in Triple-Negative and HER2-Positive Breast Cancer. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-16.
Sharma P, Connolly RM, Roussos Torres ET, Thompson A. PMID: 32315235.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors. Front Bioeng Biotechnol. 2020; 8:141.
Wang H, Sové RJ, Jafarnejad M, Rahmeh S, Jaffee EM, Stearns V, Roussos Torres ET, Connolly RM, Popel AS. PMID: 32158754; PMCID: PMC7051945.
View in:
PubMed Mentions:
35
-
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data. Cancer Res. 2019 10 01; 79(19):5102-5112.
Davis-Marcisak EF, Sherman TD, Orugunta P, Stein-O'Brien GL, Puram SV, Roussos Torres ET, Hopkins AC, Jaffee EM, Favorov AV, Afsari B, Goff LA, Fertig EJ. PMID: 31337651; PMCID: PMC6844448.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
A CD40 Agonist and PD-1 Antagonist Antibody Reprogram the Microenvironment of Nonimmunogenic Tumors to Allow T-cell-Mediated Anticancer Activity. Cancer Immunol Res. 2019 03; 7(3):428-442.
Ma HS, Poudel B, Torres ER, Sidhom JW, Robinson TM, Christmas B, Scott B, Cruz K, Woolman S, Wall VZ, Armstrong T, Jaffee EM. PMID: 30642833; PMCID: PMC6397686.
View in:
PubMed Mentions:
80 Fields:
Translation:
AnimalsCells
-
Optimizing HER2-Directed Therapy in Early-Stage Breast Cancer. Current Breast Cancer Reports. 2018.
Roussos Torres ET, Connolly RM. View Publication.
-
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs. Cancer Immunol Res. 2018 12; 6(12):1561-1577.
Christmas BJ, Rafie CI, Hopkins AC, Scott BA, Ma HS, Cruz KA, Woolman S, Armstrong TD, Connolly RM, Azad NA, Jaffee EM, Roussos Torres ET. PMID: 30341213; PMCID: PMC6279584.
View in:
PubMed Mentions:
144 Fields:
Translation:
AnimalsCells
-
N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci. 2012 Feb 01; 125(Pt 3):724-34.
Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. PMID: 22389406; PMCID: PMC3367832.
View in:
PubMed Mentions:
162 Fields:
Translation:
AnimalsCells
-
Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat Protoc. 2011 Sep 08; 6(10):1500-20.
Entenberg D, Wyckoff J, Gligorijevic B, Roussos ET, Verkhusha VV, Pollard JW, Condeelis J. PMID: 21959234; PMCID: PMC4028841.
View in:
PubMed Mentions:
86 Fields:
Translation:
Animals
-
Chemotaxis in cancer. Nat Rev Cancer. 2011 Jul 22; 11(8):573-87.
Roussos ET, Condeelis JS, Patsialou A. PMID: 21779009; PMCID: PMC4030706.
View in:
PubMed Mentions:
464 Fields:
Translation:
HumansAnimalsCells
-
Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J Cell Sci. 2011 Jul 01; 124(Pt 13):2120-31.
Roussos ET, Balsamo M, Alford SK, Wyckoff JB, Gligorijevic B, Wang Y, Pozzuto M, Stobezki R, Goswami S, Segall JE, Lauffenburger DA, Bresnick AR, Gertler FB, Condeelis JS. PMID: 21670198; PMCID: PMC3113666.
View in:
PubMed Mentions:
124 Fields:
Translation:
AnimalsCells
-
Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Clin Exp Metastasis. 2011 Aug; 28(6):515-27.
Roussos ET, Goswami S, Balsamo M, Wang Y, Stobezki R, Adler E, Robinson BD, Jones JG, Gertler FB, Condeelis JS, Oktay MH. PMID: 21484349; PMCID: PMC3459587.
View in:
PubMed Mentions:
54 Fields:
Translation:
HumansAnimalsCells
-
Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors. Breast Cancer Res. 2010; 12(6):R101.
Roussos ET, Wang Y, Wyckoff JB, Sellers RS, Wang W, Li J, Pollard JW, Gertler FB, Condeelis JS. PMID: 21108830; PMCID: PMC3046446.
View in:
PubMed Mentions:
57 Fields:
Translation:
AnimalsCells
-
AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. Cancer Res. 2010 Oct 01; 70(19):7360-4.
Roussos ET, Keckesova Z, Haley JD, Epstein DM, Weinberg RA, Condeelis JS. PMID: 20823151.
View in:
PubMed Mentions:
46 Fields:
Translation:
HumansAnimalsCells
-
Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. Cancer Res. 2009 Dec 01; 69(23):8868-76.
Pang H, Flinn R, Patsialou A, Wyckoff J, Roussos ET, Wu H, Pozzuto M, Goswami S, Condeelis JS, Bresnick AR, Segall JE, Backer JM. PMID: 19903845; PMCID: PMC2793177.
View in:
PubMed Mentions:
57 Fields:
Translation:
HumansAnimalsCells
-
A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell. 2008 Dec; 15(6):813-28.
Philippar U, Roussos ET, Oser M, Yamaguchi H, Kim HD, Giampieri S, Wang Y, Goswami S, Wyckoff JB, Lauffenburger DA, Sahai E, Condeelis JS, Gertler FB. PMID: 19081071; PMCID: PMC2637261.
View in:
PubMed Mentions:
164 Fields:
Translation:
HumansAnimalsCells
-
Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains. Biochim Biophys Acta. 2006 Apr; 1762(4):440-6.
Mao HZ, Roussos ET, Péterfy M. PMID: 16481151.
View in:
PubMed Mentions:
24 Fields:
Translation:
AnimalsCells
-
The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. Clin Cancer Res. 2003 Mar; 9(3):1136-44.
Ma MH, Yang HH, Parker K, Manyak S, Friedman JM, Altamirano C, Wu ZQ, Borad MJ, Frantzen M, Roussos E, Neeser J, Mikail A, Adams J, Sjak-Shie N, Vescio RA, Berenson JR. PMID: 12631619.
View in:
PubMed Mentions:
109 Fields:
Translation:
HumansCells
-
Identification of polymorphisms of the IkappaBalpha gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet. 2002 Aug; 137(1):43-8.
Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M, Mikail A, Roussos E, Sjak-Shie N, Vescio RA, Berenson JR. PMID: 12377412.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansCells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs